Dossier
Steve Leffler
Coverage of Steve Leffler in the Nexus archive.
- UVM Health to suspend weight loss drug coverage for its employees
UVM Health plans to stop covering weight loss medications for employees starting September 2023, aiming to save $19 million annually. The decision affects GLP-1 drugs like Ozempic and Zepbound, which are costly out-of-pocket for employees, while coverage for diabetes treatment remains. Employees express concern over financial burden and health impacts.
- UVM Health cuts 142 jobs — an estimated $9 million in staff positions
UVM Health cut 142 jobs across its Vermont and New York hospitals and hospice network, primarily administrative roles, to save $9 million annually amid financial pressures. The layoffs and reassignments follow recommendations to reduce spending and address revenue declines from insurers.